Abstract Article

research6

Standardization of marketed preparation GH Pain Nil Powder for antiinflammatory and analgesic action

Basant Rathore, Sandeep Jain

ONLINE ISSN : 2456-8244


INSTRUCTIONS TO AUTHORS

ABSTRACT

The primary objective of the current investigation was to standardize the formulation GH Pain Nil Powder, marketed for management of joint pain according to the WHO guidelines for establishing scientific evidence for applicability of the formulation for human use. The procured pouches of GHPN were yellowish-brown in color, with characteristic odor and bitter taste. They were available as granular powder (Churna). GHPN exhibited 8.9% total ash with 2.65% acid insoluble ash and 5.1% water soluble ash. The water soluble and alcohol soluble extractives were 1.48% and 1.4% respectively suggesting the formulation to be suitable for human use.The results of preliminary qualitative phytochemical screening revealed that except proteins and amino acids all the classes of phytochemicals were present in GHPN. TLC analysis of GHPN was done using Allicin as the marker using ethylacetate: chloroform: water (5:3:1) as the solvent system. Allicin appeared at Rf value of 0.61 on the TLC plate as bluish-green spot. The quantitation of the Allicin was done by HPLC method and it was found that GHPN contained 4.12 µg Allicin per 5 g of GHPN. The anti-inflammatory activity was evaluated using carrageenan induced rat paw edema method and it was seen that GHPN was able to inhibit only 28.27% edema formation in rat paws. The analgesic action of GHPN was evaluated using tail flick method and the response time pain stimulus (thermal) was observed. The highest reaction time for GHPN was 6.26 ± 0.053 sec at 60 min post administration while it was 3.48 ± 0.079 sec and 7.23 ± 0.151 sec for saline and Ibuprofen respectively at the same time duration.

KEYWORDS

Standardization, herbal, Allicin, anti-inflammatory, analgesic, extractives

DOI

REFERENCES

  1. Batiha GE-S, Beshbishy AM, Wasef LG, Elewa YHA, Al-Sagan AA, Abd El-Hack ME, Taha AE, Abd-Elhakim YM, Devkota HP. Chemical constituents and pharmacological activities of Garlic (Allium sativum L.): A review. Nutrients, 2020; 12(3): 872. doi:10.3390/nu12030872
  2. Chong K, Zamora MP, Dileshni A, Tilakawardane Nancy EB, James AR, Liu Y. Investigation of allicin stability in aqueous garlic extract by high performance liquid chromatography method. J Scientific Res reports, 20156; 4: 590-598.
  3. Fan S-H, Ali NA, Basri DF. Evaluation of Analgesic Activity of the Methanol Extract from the Galls of Quercus infectoria (Olivier) in Rats. Evidence-Based Complementary and Alternative Medicine, 2014;  http://dx.doi.org/10.1155/2014/976764
  4. Gautam V, Raman RMV and Ashish K. Exporting Indian healthcare (Export potential of Ayurveda and Siddha products and services) Road beyond boundaries (The case of selected Indian healthcare systems). Export-Import Bank of India, Mumbai, 2003; 4–54.
  5. Kemisetti D, Manda S. Synthesis and comparison of peg-ibuprofen and peg-ketoprofen prodrugs by in vitro and in vivo evaluation. J Drug Del Ther, 2018; 8(4): 145-154.
  6. Kochhar SL. 1981. Tropical crops: A textbook of economy botany. London: Macmillan Pub Ltd.268–71.
  7. Mathialagan R, Mansor N, Shamsuddin MR, Uemura Y, Majeed Z. Optimisation of Ultrasonic-Assisted Extraction (UAE) of Allicin from Garlic (Allium sativum L.). Chemical Engineering Transactions, 2017; 56: 1747-1752
  8. Meena AK et al. Standardisation of Ayurvedic polyherbal formulation, Pancasama Churna. International Journal of Pharmacognosy and Phytochemical Research, 2010; 1: 11-14.
  9. Mehta S, Singh RP, Saklani P. Phytochemical screening and TLC profiling of various extracts of Reinwardtia indica. Int J Pharmacogn Phytochem Res, 2017; 9(4): 523-527.
  10. Mukerjee PK. Quality control of herbal drugs, Business horizons Pharmaceutical publisher, New Delhi, 2002.
  11. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Nat Acad Sci, 1994; 91:12013–12017.
  12. Vaidya ADB and Devasagayam TPA. Current status of herbal drugs in India: An overview. J Clin Biochem, 2007; 41(1):1–11.
  13. Wani MS. Herbal medicine and its standardization. Pharmaceutical Reviews, 2007; 5(6).
  14. WHO (1998). Quality Control Methods for Medicinal Plant Materials, World Health Organization, Geneva.
  15. Yadav NP and Dixit VK. Recent approaches in herbal drug standardization. Int J Integr Biol, 2008; 2:195-203.
  16. Zafar R, Panwar R and SagarBhanu PS. Herbal drug standardization. The Indian Pharmacist, 2005; 4(36):21-25.